New Parkinson’s Treatments in the Clinical Trial Pipeline for ...
Sep 26, 2023 — Extensive research is underway to develop new medications for Parkinson's disease (PD), with several promising candidates at different stages of development.
A Potential Parkinson’s Treatment Has Promising Results
Jun 20, 2024 — A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based...
New Treatments for Parkinson’s Disease | APDA
Oct 19, 2021 — Exploring seven recently approved Parkinson’s treatments. Update: View our updated post of new Parkinson’s treatments in the clinical trial pipeline for 2023 and 2024. Remarkably, in the last five years, seven new medications have been approved for the treatment of the motor symptoms of Parkinson’s disease (PD), with two approved in 2020.
FDA Approves New Treatment for Advanced Parkinson’s Disease
Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help...
New Parkinson’s drug could slow or reverse progression of ...
Aug 21, 2024 — New Parkinson’s drug could slow or reverse progression of disease, researchers say: ‘Big step forward’. Published On. August 21, 2024. Social Media. Share this article. “People with Parkinson’s should be aware that although the findings were interesting, this was only a safety, tolerability and immunogenicity study, and thus there is ...
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial
Mar 11, 2024 — Produced by the US biotechnology company Vaxxinity, the immunotherapy candidate codenamed UB-312 is the first treatment shown to be capable of reducing concentrations of alpha-synuclein (α-syn) in cerebrospinal fluid, marking a significant step forward in slowing – or even halting – the disorder's progress.
Novel cell therapy continues to show promise for Parkinson's ...
Mar 6, 2024 — Orange, Calif. — New clinical trial data for bemdaneprocel, a promising stem cell-derived therapy for Parkinson’s disease, continues to show positive results 18 months after treatment, scientists reported today at an international conference in Portugal.
Promising Parkinson’s therapy gets FDA investigational nod
Jun 6, 2024 — A cellular therapy to treat Parkinson's disease is given Regenerative Medicine Advanced Therapy designation by the U.S. Food and Drug Administration, putting it on a fast track for review.
New Findings About Key Pathological Protein in Parkinson’s ...
Dec 18, 2023 — Researchers from the Johns Hopkins University School of Medicine who conducted the study say the findings offer potential new targets for treating Parkinson’s disease, which affects about 1% of the U.S. population over age 60 and has no cure.
Promising results for Parkinson's disease treatment
Oct 7, 2021 — Researchers from Carnegie Mellon University have found a way to make deep brain stimulation (DBS) more precise, resulting in therapeutic effects that outlast what is currently available. The work...
- Some results have been removed